COLUMBIA, Md.--(BUSINESS WIRE)--Jan. 19, 2006--CELSION CORPORATION (AMEX:CLN) today announced that it had appointed William Hahne M.D., as Vice President Clinical Development and Medical Affairs and Christopher Black, Ph.D. as Executive Director, Preclinical Research. Dr. Hahne has extensive experience in the management of clinical trial programs including oncology drug trial design and implementation. In his most recent position as Vice President, Clinical Development at Curagen Corporation, Dr. Hahne managed all clinical aspects of the company’s oncology drug development program. Prior to Curagen from 1986 to 2002, he served in increasingly senior positions at Glaxo Inc., Hoechst Marion Roussel and Eisai Inc., Dr. Hahne earned his M.D. at Cornell University Medical School.
